Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared on LinkedIn about a recent article by Antoine Babuty et al, published in Nature Bone Research:
”Hemophilia A (HA) has long been known as a bleeding disorder caused by deficient Factor VIII (FVIII), leading to life-impacting joint bleeds and muscle degeneration.
But what if FVIII’s role extends far beyond just stopping bleeds?
A recently published study using FVIII knockout mice uncovered a surprising story: FVIII deficiency triggers early osteoporosis, disrupted bone vascularization, and muscle abnormalities
a complex musculoskeletal disruption that mirrors patients’ real-life challenges.
Even more promising, intravenous recombinant FVIII treatment not only restored bone density and vascular health but partially reversed muscle metabolic defects.
This suggests FVIII acts as a critical regulator of bone remodeling and muscle metabolism, not just coagulation.
For those living with HA, these insights kindle hope for therapies that protect bones and muscles, improving quality of life beyond bleeding control.
Science is rewriting what we know about FVIII, transforming how we understand, treat, and support hemophilia.
The journey continues.”
Title: Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice
Authors: Antoine Babuty, Javier Muñoz-Garcia, Olivier D. Christophe, Laurie Fradet, Manon Taupin, Denis Cochonneau, Emilie Ollivier, Frank Driessler, Claudia Lange, Oleksandr Boychenko, Marie-Françoise Heymann, Dominique Heymann
Read the Full Article on Nature Bone Research

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound